These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27446417)

  • 1. First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the
    Jouali F; Laarabi FZ; Marchoudi N; Ratbi I; Elalaoui SC; Rhaissi H; Fekkak J; Sefiani A
    Oncol Lett; 2016 Aug; 12(2):1192-1196. PubMed ID: 27446417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
    Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
    Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control.
    Laarabi FZ; Ratbi I; Elalaoui SC; Mezzouar L; Doubaj Y; Bouguenouch L; Ouldim K; Benjaafar N; Sefiani A
    BMC Res Notes; 2017 Jun; 10(1):188. PubMed ID: 28577564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing of
    Balabanski L; Antov G; Dimova I; Ivanov S; Nacheva M; Gavrilov I; Nesheva D; Rukova B; Hadjidekova S; Malinov M; Toncheva D
    Mol Clin Oncol; 2014 May; 2(3):435-439. PubMed ID: 24772314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
    Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
    BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).
    El Ansari FZ; Jouali F; Marchoudi N; Bennani MM; Ghailani NN; Barakat A; Fekkak J
    BMC Cancer; 2020 Aug; 20(1):747. PubMed ID: 32778078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Globally Rare
    Oosthuizen J; Kotze MJ; Van Der Merwe N; Myburgh EJ; Bester P; van der Merwe NC
    Front Oncol; 2020; 10():619469. PubMed ID: 33643918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
    Hwang SM; Lee KC; Lee MS; Park KU
    Cancer Res Treat; 2018 Jan; 50(1):255-264. PubMed ID: 28392550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer.
    Trujillano D; Weiss ME; Schneider J; Köster J; Papachristos EB; Saviouk V; Zakharkina T; Nahavandi N; Kovacevic L; Rolfs A
    J Mol Diagn; 2015 Mar; 17(2):162-70. PubMed ID: 25556971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing of
    Nicolussi A; Belardinilli F; Mahdavian Y; Colicchia V; D'Inzeo S; Petroni M; Zani M; Ferraro S; Valentini V; Ottini L; Giannini G; Capalbo C; Coppa A
    PeerJ; 2019; 7():e6661. PubMed ID: 31065452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory.
    Strom CM; Rivera S; Elzinga C; Angeloni T; Rosenthal SH; Goos-Root D; Siaw M; Platt J; Braastadt C; Cheng L; Ross D; Sun W
    PLoS One; 2015; 10(8):e0136419. PubMed ID: 26295337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing.
    Hirotsu Y; Nakagomi H; Sakamoto I; Amemiya K; Mochizuki H; Omata M
    Mol Genet Genomic Med; 2015 Mar; 3(2):121-9. PubMed ID: 25802882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
    Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR
    Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
    Ozcelik H; Shi X; Chang MC; Tram E; Vlasschaert M; Di Nicola N; Kiselova A; Yee D; Goldman A; Dowar M; Sukhu B; Kandel R; Siminovitch K
    J Mol Diagn; 2012 Sep; 14(5):467-75. PubMed ID: 22874498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
    Górski B
    Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.
    Machackova E; Claes K; Mikova M; Házová J; Sťahlová EH; Vasickova P; Trbusek M; Navrátilová M; Svoboda M; Foretová L
    Klin Onkol; 2019; 32(Supplementum2):51-71. PubMed ID: 31409081
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.